Concord Wealth Partners Lemaitre Vascular Inc Transaction History
Concord Wealth Partners
- $591 Million
- Q3 2024
A detailed history of Concord Wealth Partners transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Concord Wealth Partners holds 59 shares of LMAT stock, worth $5,435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 51
15.69%
Holding current value
$5,435
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LMAT
# of Institutions
291Shares Held
20.4MCall Options Held
5.2KPut Options Held
2.9K-
Black Rock Inc. New York, NY3.48MShares$320 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.98MShares$182 Million2.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$145 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.16MShares$107 Million1.93% of portfolio
-
Geneva Capital Management LLC878KShares$80.9 Million1.39% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $2.02B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...